Copyright
©The Author(s) 2016.
World J Gastrointest Endosc. Dec 16, 2016; 8(20): 785-794
Published online Dec 16, 2016. doi: 10.4253/wjge.v8.i20.785
Published online Dec 16, 2016. doi: 10.4253/wjge.v8.i20.785
No. | Question | Answer (n = 37) | High volume (n = 18) | Low volume (n = 19) | P value | East Japan (n = 21) | West Japan (n = 16) | P value |
18 | What kind of endoscopic treatment do you perform as first-line therapy? | |||||||
Clipping | 31 (83.8) | 15 (48.4) | 16 (51.6) | 1.000 | 17 (54.8) | 14 (45.2) | ||
Endoscopic band ligation | 5 (13.5) | 3 (60.0) | 2 (40.0) | 3 (60.0) | 2 (40.0) | |||
Epinephrine injection | 1 (2.7) | 0 | 1 (100) | 1 (100) | 0 | 1.000 | ||
19 | What kinds of patient undergo non-endoscopic therapy?1 | |||||||
Patients with an unidentified bleeding source | 18 (48.7) | 10 (55.6) | 8 (44.4) | 0.413 | 8 (44.4) | 10 (55.6) | 0.141 | |
Patients with rebleeding | 27 (73.0) | 15 (55.6) | 12 (44.4) | 0.269 | 17 (63.0) | 10 (37.0) | 0.274 | |
Patients with hemorrhagic shock | 25 (67.6) | 15 (60.0) | 10 (40.0) | 0.079 | 13 (52.0) | 12 (48.0) | 0.491 | |
20 | What kind of non-endoscopic therapy do you perform as first-line therapy or when you are unable to identify SRH at endoscopy? | |||||||
IVR | 24 (77.4) | 2 (50.0) | 2 (50.0) | 0.253 | 10 (41.7) | 14 (58.3) | ||
Surgery | 3 (9.7) | 14 (58.3) | 10 (41.7) | 3 (100) | 0 | |||
Barium impaction therapy | 4 (12.9) | 0 | 3 (100) | 3 (75.0) | 1 (25.0) | 0.145 | ||
21 | What kind of treatment do you perform to prevent rebleeding?1 | |||||||
Treatment of diabetes mellitus | 0 | 0 | 0 | NA | 0 | 0 | NA | |
Treatment of hypertension | 6 (17.1) | 2 (33.3) | 4 (66.7) | 0.658 | 3 (50.0) | 3 (50.0) | 1.000 | |
Discontinuation NSAIDs | 14 (40.0) | 7 (50.0) | 7 (50.0) | 0.890 | 10 (71.4) | 4 (28.6) | 0.296 | |
Discontinuation antithrombotic drugs | 22 (62.9) | 11 (50.0) | 11 (50.0) | 0.826 | 15 (68.2) | 7 (31.8) | 0.086 | |
Administrating vitamin D | 0 | 0 | 0 | NA | 0 | 0 | NA | |
Treatment of constipation | 14 (40.0) | 9 (64.3) | 5 (35.7) | 0.129 | 6 (42.9) | 8 (57.1) | 0.163 | |
Administrating a low fiber diet | 5 (14.3) | 2 (40.0) | 3 (60.0) | 1.000 | 3 (60.0) | 2 (40.0) | 1.000 | |
22 | Do you discontinue antithrombotic drugs on admission? | |||||||
Yes | 22 (59.5) | 10 (45.5) | 12 (54.5) | 12 (54.6) | 10 (46.4) | |||
No | 12 (32.4) | 7 (58.3) | 5 (41.7) | 6 (50.0) | 6 (50.0) | |||
Case by case | 3 (8.1) | 1 (33.3) | 2 (66.7) | 0.693 | 3 (100) | 0 | 0.398 | |
23 | Do you have a strategy for restarting antithrombotic drugs?2 | |||||||
Yes | 4 (15.4) | 4 (100) | 0 | 0 | 4 (100) | |||
No | 22 (84.6) | 6 (27.3) | 16 (72.7) | 0.014 | 15 (68.2) | 7 (31.8) | 0.022 |
- Citation: Niikura R, Nagata N, Doyama H, Ota R, Ishii N, Mabe K, Nishida T, Hikichi T, Sumiyama K, Nishikawa J, Uraoka T, Kiyotoki S, Fujishiro M, Koike K. Current state of practice for colonic diverticular bleeding in 37 hospitals in Japan: A multicenter questionnaire study. World J Gastrointest Endosc 2016; 8(20): 785-794
- URL: https://www.wjgnet.com/1948-5190/full/v8/i20/785.htm
- DOI: https://dx.doi.org/10.4253/wjge.v8.i20.785